Details for 2016750078
Up to date per 01.04.2026
Actions
Details for 2016750078
Granted/Registered
European Patent
20.12.2017 A
23.02.2022 B1
25.11.2015
US
201562259993 P
A61K 9/20 20060101AFI20210715BHEP
Owner
Axsome Therapeutics, Inc.22 Cortlandt Street, 16th Floor New York, NY 10007US
Representative
Representative
Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT
Inventor
TABUTEAU, Herriot22 Cortlandt Street, 16th Floor New York, NY 10007US
Information about Fees